human intracellular isg15 prevents interferon-alpha/beta over-amplification auto-inflammation 
intracellular isg15 interferon ifn-alpha/beta-inducible ubiquitin-like modifier can covalently bind proteins process called isgylation; effector ifn-alpha/beta-dependent antiviral immunity mice1- previously published study describing humans inherited isg15deficiency without unusually severe viral diseases5 showed patients prone mycobacterial disease human isg15 non-redundant extracellular ifn-gamma-inducing molecule show isg15-deficient patients also display unanticipated cellular immunological clinical signs enhanced ifn-alpha/beta immunity reminiscent mendelian autoinflammatory interferonopathies aicardi-goutieres syndrome spondyloenchondrodysplasia6- show absence intracellular isg15 patients cells prevents accumulation usp181011 potent negative regulator ifn-alpha/beta signalling resulting enhancement amplification ifn-alpha/beta responses human isg15 therefore redundant antiviral immunity key negative regulator ifn-alpha/beta immunity humans intracellular isg15 ifn-alpha/beta-inducible serve substrate isgylation-dependent antiviral immunity ensure usp18-dependent regulation ifn-alpha/beta prevention ifn-alpha/beta-dependent autoinflammation 
